<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">Despite the large outbreaks in 2015-2016, subsequent years have been relatively quiet in terms of ZIKV. In the United States and US territories, there were over 41,000 cases in 2016, fewer than 1200 cases in 2017, and only 220 cases in 2018.
 <xref rid="bib3" ref-type="bibr">
  <sup>3</sup>
 </xref> The rest of the world has experienced a similar situation; nonetheless, much of the world is at risk, and the many people who travel are also at risk. Travelers from endemic areas can also introduce ZIKV into the new territories.
 <xref rid="bib4" ref-type="bibr">4</xref>, 
 <xref rid="bib5" ref-type="bibr">5</xref>, 
 <xref rid="bib6" ref-type="bibr">6</xref> This scenario begs the question of what the future holds for this virusâ€”continued low-level circulation, outbreaks in new locations, or recurrent outbreaks once population immunity wanes or as the percentage of naive individuals in a population increases?
 <xref rid="bib7" ref-type="bibr">7</xref>, 
 <xref rid="bib8" ref-type="bibr">8</xref>, 
 <xref rid="bib9" ref-type="bibr">9</xref>, 
 <xref rid="bib10" ref-type="bibr">10</xref>, 
 <xref rid="bib11" ref-type="bibr">11</xref> The current unpredictability and lack of future ZIKV outbreaks is a major impediment to creating effective public health policies, disease surveillance, and control measures (including continued clinical vaccine development and studies).
</p>
